NCT02722070

Brief Summary

The main objective of the study is to explore and map brain areas involved in processing and perception in patients suffering from neurological pathologies and condition. The investigators hypothesize for example, that a change (compare to healthy subjects) in the perceptual maps and body representation could be detected and characterize in patients suffering from impairments of peripheral nerve conduction.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2016

Longer than P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2016

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

March 23, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 29, 2016

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

March 29, 2016

Status Verified

January 1, 2016

Enrollment Period

4 years

First QC Date

March 23, 2016

Last Update Submit

March 28, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Hemodynamic responses by measurement of the Blood-oxygen-level dependence(BOLD) signal

    Distinct maps of sensory and multisensory representations related to certain disorders will be sassed by measurement of the Blood-oxygen-level dependence(BOLD) signal.

    2 years

Study Arms (4)

Healthy Controls

Age matched control for the various clinical groups

Device: 3 Tesla Siemens Skyra MRI scanner

Neurodegenerative patients

Device: 3 Tesla Siemens Skyra MRI scanner

Stroke patients

Device: 3 Tesla Siemens Skyra MRI scanner

Neuropsychiatric patients

Device: 3 Tesla Siemens Skyra MRI scanner

Interventions

Standardly used Magnetic resonance imaging (MRI) protocols, including resting state fMRI, task fMRI, T1 weighted imaging

Healthy ControlsNeurodegenerative patientsNeuropsychiatric patientsStroke patients

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients suffering from central and peripheral neurological pathologies and conditions

You may qualify if:

  • diagnosis of the investigated neuronal disease

You may not qualify if:

  • contraindication for MRI scan
  • pregnancy
  • refusal to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Arzy S, Overney LS, Landis T, Blanke O. Neural mechanisms of embodiment: asomatognosia due to premotor cortex damage. Arch Neurol. 2006 Jul;63(7):1022-5. doi: 10.1001/archneur.63.7.1022.

MeSH Terms

Conditions

Guillain-Barre SyndromeStrokeAgnosia

Condition Hierarchy (Ancestors)

PolyradiculoneuropathyAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesPolyneuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesAutoimmune DiseasesImmune System DiseasesPost-Infectious DisordersChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesCardiovascular DiseasesPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsSigns and Symptoms

Central Study Contacts

Shahar Arzy, M.D, Ph.D

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 23, 2016

First Posted

March 29, 2016

Study Start

March 1, 2016

Primary Completion

March 1, 2020

Study Completion

March 1, 2025

Last Updated

March 29, 2016

Record last verified: 2016-01

Data Sharing

IPD Sharing
Will not share